M&A Mode! Future Is Bright!

[anonymous]

I’ll retire here!

Merck & Co. remains in a deal-hunting mode despite its recent $11.5 billion acquisition for Acceleron. Merck CEO Rob Davis is actively piecing together a plan for life after Keytruda, and the company seems to already have a list of potential targets.

 

[anonymous]

I’ll retire here!

Merck & Co. remains in a deal-hunting mode despite its recent $11.5 billion acquisition for Acceleron. Merck CEO Rob Davis is actively piecing together a plan for life after Keytruda, and the company seems to already have a list of potential targets.

You still believe in the Tooth Fairy, don't you? You should also know they are aggressively pursuing plans to cut costs and downsize the company, significantally reduce our cost structure. Hopefully your plans to retire here are not derailed by being part of the cuts.

 

[anonymous]

You still believe in the Tooth Fairy, don't you? You should also know they are aggressively pursuing plans to cut costs and downsize the company, significantally reduce our cost structure. Hopefully your plans to retire here are not derailed by being part of the cuts.

Truth...aggressive budget targets, cutting billions in cost across the company over the next 3-5 years.